Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)

NCT06008197 is registered in ClinicalTrials.gov with Colorado Prevention Center as lead sponsor.

NCT NCT06008197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)
Lead sponsor
Colorado Prevention Center
Phase
Phase 3
Overall status
Recruiting
Start date
January 17, 2024
Completion date
December 31, 2027
Enrollment
5,200 (estimated)
Sites
356

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, heart failure